A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush immunotherapy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 7, 1996, Pages 489-500

  Dolz, I ^a   Martinez Cocera C ^a   Bartolome J M ^a   Cimarra, M ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Grass pollen extracts; Immunotherapy; Rush immunotherapy

Indexed keywords

ALUTARD;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHENIA; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030016756     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb00166.x     Document Type: Article

References (22)

1. Alvarez-Cuesta E, Boquete Paris M, Cadahîa Garcia A, et al. La Inmunoterapia a través de sus publicaciones: Anâlisis de los Ultimos cinco anos. Rev Esp Alerg Inmunol Clin 1992;7:55-64.
2. Bousquet J, Michel B. Specific immunotherapy. Allergy 1988;43:16-22.
3. Bousquet J, Hejjaoui A, Skassa-Brockiek W, et al. Doubleblind, placebo-controlled rush immunotherapy with allergoids and standarized orchard grass-pollen extract. J Allergy Ciin Immunol 1987;80:591-8.
4. Bousquet J, Maasch H, Martinot B, Hejjaoui A, Wahl R, Michel B. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 1988;82:439-46.
5. Bousquet J, Maasch H, Hejjaoui A, et al. Double-blind, placebo-controlled immunotherapy with mixed grasspollen allergoids. III. Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma. J Allergy Clin Immunol 1989;84:546-56.
6. Bousquet J, Hejjaoui A, Soussana M, Michel B. Doubleblind placebo-controlled immunotherapy with mixed grasspollen allergoids. IV. Comparison of the safety and efficacy for two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol 1990;80:490-7.
7. Bousquet J, Becker W, Hejjaoui A, et al. Differences in clinical and immunologie reactivity of patients allergic to grass-pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. J Allergy Clin Immunol 1991;88:43-53.
8. Corrado J, Pastorello E, Oilier S, et al. A double-blind study of hyposensitization with an alginate-conjugated extract of D. pteronyssinus (Conjuvac) in patients with perennial rhinitis. Allergy 1989;14:108-15.
9. Munoz D, Bernaola G, Fernândez E, et al. Seasonal versus perennial immunotherapy: evaluation after three years of treatment. J Invest Allergol Clin Immunol 1993;3:210-16.
10. Norman P. Postgraduate course presentation. An overview of immunotherapy implications for the future. J Allergy Clin Immunol 1980;65:87-96.
11. Alvarez-Cuesta E, Boquete M, Cadahi'a A, et al. Bases para la realizaciôn de un ensayo clînico sobre inmunoterapia. Rev Esp Alerg Inmunol Clin 1993;8:37-42.
12. Basomba A. Inmunoterapia en pacientes polfnicos: estudio doble ciego. Rev Esp Alerg Inmunol Clin 1991;6:22-7.
13. Dreborg S, Agreli B, Foucard T, Kjellman M, Korvikko A, Nilsson S. A double-blind multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results. Allergy 1986;41:131-40.
14. Malet A, Lluch M, Valero A, Amat P. Parameters of immunotherapy: a retrospective study. Allergol Immunopathol (Madr) 1993;21(1):7-10
15. Garcîa B, Sanz ML, Dfeguez I, de las Marinas D, Oehling A. Modifications in IgG subclasses in the course of immunotherapy with grass-pollen. J Invest Allergol Clin Immunol 1993;3:19-25.
16. Karlsson R, Agrell B, Dreborg S, et al. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. II. /// vitro results. Allergy 1986;41:141-50.
17. Pastorello EA, Ortollani C, Incorvaia C, et al. A doubleblind study of hyposensitization with an alginateconjugated extract of Dermatopliagoides pteronyssinus (Conjuvac) in patients with perennial rhinitis. II. Immunological aspects. Allergy 1990;45:505-14.
18. Pastorello EA, Pravettoni V, Incorvaia C, et al. Clinical and immunological effects of immunotherapy with alumabsorbed grass allergoid in grass-pollen-induced hay fever. Allergy 1992;47:281-90.
19. Munoz D, Bernaola G, Audicana M, Fernändez E, Femândez de Corres L. Inmunoterapia Râpida en pacientes polfnicos. Evoluciôn clinica y variaciôn de paramètres in vivo e in vitro. Rev Esp Alerg Inmunol Clin 1991;6:5777.
20. Fernändez Tâvora L, Garcia D. Inmunoterapia cluster con extracto de pölenes: estudios de tolerancia, cambios inmunolôgicos y eficacia clînica. Rev Esp Alerg Inmunol Clin 1991;6:68-74.
21. Horst M, Hejjaoui A, Horts V, Michel B, Bousquet J. Double-blind placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol 1990;85:460-72.
22. Varney V, Gaga M, Frew A, Aber V, Kay AB, Durham S. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991;302:265-9.